Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Current PARP inhibitors undergoing clinical evaluation
| Inhibitor | Other name(s) | Company |
|---|---|---|
| Olaparib | AZD2281, KU0059436 | AstraZeneca |
| Veliparib | ABT-888 | Abbvie |
| Niraparib | MK-4827 | Tesaro |
| Talazoparib | BMN-673 | BioMarin Pharmaceuticals |
| Rucaparib | AG-14699 | Clovis Oncology |
| CEP-9722 | Teva Pharmaceutical Industries | |
| SC10914 | Jiangxi Qingfeng Pharmaceutical Co. Ltd. |
